Brian David  Archbold net worth and biography

Brian Archbold Biography and Net Worth

Brian Archbold joined Mesa in January 2018 as Senior Vice President, Continuous Improvement. From January 2015 to 2018, Mr. Archbold worked for Quadion LLC, a global manufacturer of medical and automotive components, as Vice President of Global Operations. From September 2012 to January 2015, Mr. Archbold was Director of Operations for Beckman Coulter, part of the Danaher Corporation. Prior to Danaher, Brian was with Thermo Fisher Scientific where he held various senior leadership positions of progressive responsibility in Operations.

Mr. Archbold began his career with IBM in Supply Chain Management. Mr. Archbold has a Bachelor of Science degree from Central Michigan University and his MBA from Michigan State University.

What is Brian David Archbold's net worth?

The estimated net worth of Brian David Archbold is at least $55,587.96 as of December 15th, 2023. Mr. Archbold owns 558 shares of Mesa Laboratories stock worth more than $55,588 as of April 18th. This net worth estimate does not reflect any other investments that Mr. Archbold may own. Additionally, Mr. Archbold receives a salary of $485,590.00 as SVP at Mesa Laboratories. Learn More about Brian David Archbold's net worth.

How old is Brian David Archbold?

Mr. Archbold is currently 48 years old. There are 2 older executives and no younger executives at Mesa Laboratories. The oldest executive at Mesa Laboratories is Mr. Gary M. Owens, CEO, President & Director, who is 56 years old. Learn More on Brian David Archbold's age.

What is Brian David Archbold's salary?

As the SVP of Mesa Laboratories, Inc., Mr. Archbold earns $485,590.00 per year. There are 2 executives that earn more than Mr. Archbold. The highest earning executive at Mesa Laboratories is Mr. Gary M. Owens, CEO, President & Director, who commands a salary of $1,020,000.00 per year. Learn More on Brian David Archbold's salary.

How do I contact Brian David Archbold?

The corporate mailing address for Mr. Archbold and other Mesa Laboratories executives is 12100 W 6TH AVE, LAKEWOOD CO, 80228. Mesa Laboratories can also be reached via phone at (303) 987-8000 and via email at [email protected]. Learn More on Brian David Archbold's contact information.

Has Brian David Archbold been buying or selling shares of Mesa Laboratories?

Brian David Archbold has not been actively trading shares of Mesa Laboratories within the last three months. Most recently, Brian David Archbold sold 1,500 shares of the business's stock in a transaction on Friday, December 15th. The shares were sold at an average price of $112.36, for a transaction totalling $168,540.00. Following the completion of the sale, the senior vice president now directly owns 558 shares of the company's stock, valued at $62,696.88. Learn More on Brian David Archbold's trading history.

Who are Mesa Laboratories' active insiders?

Mesa Laboratories' insider roster includes Brian Archbold (SVP), Gregory DiNoia (SVP), Evan Guillemin (Director), David Kelly (Director), Gary Owens (CEO), John Sakys (CFO), John Schmieder (Director), and John Sullivan (Director). Learn More on Mesa Laboratories' active insiders.

Are insiders buying or selling shares of Mesa Laboratories?

During the last twelve months, insiders at the medical instruments supplier sold shares 4 times. They sold a total of 7,500 shares worth more than $947,880.00. The most recent insider tranaction occured on December, 15th when SVP Brian David Archbold sold 1,500 shares worth more than $168,540.00. Insiders at Mesa Laboratories own 5.2% of the company. Learn More about insider trades at Mesa Laboratories.

Information on this page was last updated on 12/15/2023.

Brian David Archbold Insider Trading History at Mesa Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2023Sell1,500$112.36$168,540.00558View SEC Filing Icon  
6/21/2022Sell392$188.22$73,782.24813View SEC Filing Icon  
12/14/2021Sell1,659$325.02$539,208.18View SEC Filing Icon  
8/9/2021Sell639$280.03$178,939.17154View SEC Filing Icon  
3/10/2021Sell223$271.78$60,606.94377View SEC Filing Icon  
8/10/2020Sell603$250.00$150,750.00415View SEC Filing Icon  
2/21/2020Sell123$268.19$32,987.37232View SEC Filing Icon  
See Full Table

Brian David Archbold Buying and Selling Activity at Mesa Laboratories

This chart shows Brian David Archbold's buying and selling at Mesa Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mesa Laboratories Company Overview

Mesa Laboratories logo
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Read More

Today's Range

Now: $99.62
Low: $99.54
High: $103.32

50 Day Range

MA: $104.21
Low: $90.86
High: $114.10

2 Week Range

Now: $99.62
Low: $82.86
High: $178.64

Volume

31,078 shs

Average Volume

49,112 shs

Market Capitalization

$536.95 million

P/E Ratio

586.03

Dividend Yield

0.62%

Beta

0.83